| abstract |
The present invention discloses alkyldiamine derivatives having the following general structural formula or pharmaceutically acceptable salts thereof, and their use as antidepressants. The alkyldiamine derivatives have an activity capable of inhibiting triple reuptake with respect to 5-serotonin, noradrenaline and dopamine, and are in the form of a drug composition for patients who need such treatment by oral or injection. Can be administered. [Chemical 1] |